EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro anti-neovascularization and anti-angiogenic activities of Platycladus orientalis (L.) Franco in human retinal endothelial cells via Raf/MEK 1/2 and AKT1/mTOR signaling

Jing Xian Lim, Phaik Har Yong, Siew Huah Lim, Zhi Xiang Ng

Life Sciences · 2025

DOI: 10.1016/j.lfs.2025.124017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2025. Verfasst von Jing Xian Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Environmental Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, 43500, Selangor, Malaysia. Hauptthemen laut MEDLINE: Endothelial Cells, Plant Extracts, Angiogenesis Inhibitors, Retina. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Malaysia Ministry of Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study investigated the anti-neovascularization and anti-angiogenic potential of Platycladus orientalis ethyl acetate fraction (POEA) in human retinal endothelial cells (HRECs) under varying glucose conditions. METHODS: The phytochemicals in POEA were identified with liquid chromatography-mass spectrometry while POEA in vitro cytotoxicity was evaluated. Both gene and protein expression of vascular endothelial growth factor (VEGF), VEGF receptor 2 (VEGFR2), serine/threonine kinase 1 (AKT1), mammalian target of rapamycin (mTOR), rapidly accelerated fibrosarcoma-1 (Raf-1), mitogen-activated extracellular signal-regulated kinase 1 and 2 (MEK1/2) in POEA-treated group were compared to the control. Cell migration and tube formation assays were conducted using VEGF and the MEK1/2 inhibitor, U0126 as reference controls. KEY FINDINGS: Phytochemical analysis revealed monoterpene esters, diterpenoids, and phenolic glycosides in POEA. POEA with an IC₅₀ of 0.413 mg/ml preserved the HRECs viability above 80 % under high glucose stress. POEA treatment significantly attenuated high glucose-induced upregulation of VEGF, VEGFR2, mTOR, Raf-1, and MEK1/2 at both gene and protein levels while enhancing AKT1 activation, suggesting restoration of cell survival pathways. Functional assays demonstrated dose-dependent inhibition of glucose- and VEGF-induced HRECs migration and tube formation by POEA, comparable to the MEK1/2 inhibitor U0126. Mechanistically, POEA suppressed phosphorylation of VEGFR2, Raf-1, and MEK1/2, and downregulated mTOR signaling, thereby disrupting angiogenic signaling cascades critical for endothelial proliferation and migration. Combined POEA and U0126 treatment showed additive inhibitory effects, supporting a synergistic mechanism through dual blockade of VEGF-driven pathways. SIGNIFICANCE: POEA could mitigate diabetic retinopathy-related neovascularization and angiogenesis through modulation of VEGF/VEGFR2, AKT1/mTOR, and Raf-1/MEK1/2 signaling in HRECs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsPlant ExtractsAngiogenesis InhibitorsRetinaHumansTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktCell MovementSignal TransductionMAP Kinase Kinase 1Vascular Endothelial Growth Factor Receptor-2Proto-Oncogene Proteins c-rafMAP Kinase Kinase 2Cells, CulturedMAP Kinase Signaling System

Stichwörter der Autor:innen

AngiogenesisDiabetic retinopathyMedicinal plantNeovascularizationPhytochemicalToxicity

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPlant ExtractsAngiogenesis InhibitorsMTOR protein, humanAKT1 protein, humanMAP Kinase Kinase 1Vascular Endothelial Growth Factor Receptor-2Proto-Oncogene Proteins c-rafMAP Kinase Kinase 2

Autor:innen und Institutionen

  • School of Biological and Environmental Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, 43500, Selangor, Malaysia.
  • School of Bioscience, Faculty of Pharmacy and Biomedical Sciences, MAHSA University, 42610, Selangor, Malaysia.
  • Department of Chemistry, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia.
  • School of Biological and Environmental Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, 43500, Selangor, Malaysia. Electronic address: zhixiang.ng@nottingham.edu.my.

Förderung

  • Malaysia Ministry of Higher Education

Zitieren

APA

Lim, J. X., Yong, P. H., Lim, S. H., & Ng, Z. X. (2025). In vitro anti-neovascularization and anti-angiogenic activities of Platycladus orientalis (L.) Franco in human retinal endothelial cells via Raf/MEK 1/2 and AKT1/mTOR signaling. Life Sciences. https://doi.org/10.1016/j.lfs.2025.124017

Vancouver

Lim JX, Yong PH, Lim SH, Ng ZX. In vitro anti-neovascularization and anti-angiogenic activities of Platycladus orientalis (L.) Franco in human retinal endothelial cells via Raf/MEK 1/2 and AKT1/mTOR signaling. Life Sciences. 2025. doi:10.1016/j.lfs.2025.124017

BibTeX
@article{Lim2025,
  author = {Lim, Jing Xian and Yong, Phaik Har and Lim, Siew Huah and Ng, Zhi Xiang},
  title = {In vitro anti-neovascularization and anti-angiogenic activities of Platycladus orientalis (L.) Franco in human retinal endothelial cells via Raf/MEK 1/2 and AKT1/mTOR signaling},
  journal = {Life Sciences},
  year = {2025},
  doi = {10.1016/j.lfs.2025.124017}
}
Kostenlos starten →